Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director · Chairman, CEO and President | May 07, 2026 | May 11, 2026 |
| BOEING COBA · Entity 2862 | Director | July 01, 2026 | July 06, 2026 |
| NORFOLK SOUTHERN CORPNSC · Entity 2965 | Director | March 10, 2017 | March 14, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 505,160 |
Reported balance
After 2026-05-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-07 · Tax withholding · Disposed 2,079 · Balance 505,160 F1: These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 60,060 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 60,060 |
| Common StockSEC Table I · non-derivative | IndirectBy Spousal GRAT | 60,060 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 60,060 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 29,940 |
Reported balance
Holding disclosure · report date 2026-05-07 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 29,940 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include 1,273 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
BOEING CO
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 16,282.795 |
Reported balance
After 2026-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 406 · Balance 16,282.795 F1: Phantom stock units are convertible into common stock on a 1-for-1 basis. F2: Phantom stock units awarded or acquired in lieu of director cash compensation. F3: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Phantom stock units are convertible into common stock on a 1-for-1 basis.
F2: Phantom stock units awarded or acquired in lieu of director cash compensation.
F3: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.
NORFOLK SOUTHERN CORP
Report date March 10, 2017 · Filed March 14, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,717.4372 |
Reported balance
After 2017-03-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-03-10 · Grant · Acquired 59.3214 · Balance 11,717.4372 F1: Reports the number of restricted stock units credited to the reporting person's account in the Norfolk Southern Corporation Long-Term Incentive Plan in the form of dividend equivalent payments on restricted stock units held under the plan, calculated on the basis of the market value of the company's common stock on the dividend payment date. These units ultimately will be satisfied in common stock upon the reporting person's termination of service or death. |
| Common StockSEC Table I · non-derivative | Direct | 3,000 |
Reported balance
Holding disclosure · report date 2017-03-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Reports the number of restricted stock units credited to the reporting person's account in the Norfolk Southern Corporation Long-Term Incentive Plan in the form of dividend equivalent payments on restricted stock units held under the plan, calculated on the basis of the market value of the company's common stock on the dividend payment date. These units ultimately will be satisfied in common stock upon the reporting person's termination of service or death.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2015 Filed Feb 13, 2015 02:09 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 40,539 | $152.57 | $6,185,035.23 |
DisclosureSEC source: 0001127602-15-005887 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,102 F1 · balance_after: Non-market exercise of 62,000 stock options expiring April 29, 2015 wherein 40,539 shares issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and statutory tax withholding, with the remaining shares delivered to the reporting person. Read SEC document |
| February 11, 2015 Filed Feb 13, 2015 02:09 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 62,000 | $42.13 | $2,612,060.00 |
DisclosureSEC source: 0001127602-15-005887 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2015 Filed Feb 3, 2015 23:58 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 13,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-004130 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,641 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended ad Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 7,140 RSUs which vest in one installment on 4/25/2015; 14,029 RSUs which vest in two installments of 6,910 and 7,119 on 4/27/2015 and 4/27/2016, respectively; 12,525 RSUs which vest in two installments of 6,169 and 6,356 on 1/28/2016 and 1/28/2017, respectively; 15,132 RSUs which vest in three installments of 4,993, 4,994 and 5,145 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 13,398 shares which vest in two equal installments of 4,421 on 1/30/2017 and 1/30/2018 and one installment of 4,556 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 1,458 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 21:53 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 101 | $158.89 | $16,047.89 |
DisclosureSEC source: 0001127602-15-003485 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,243 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 7,140 RSUs which vest in one installment on 4/25/2015; 14,029 RSUs which vest in two installments of 6,910 and 7,119 on 4/27/2015 and 4/27/2016, respectively; 12,525 RSUs which vest in two installments of 6,169 and 6,356 on 1/28/2016 and 1/28/2017, respectively; and 15,132 RSUs which vest in three installments of 4,993, 4,994 and 5,145 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 1,458 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 21:53 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,317 | $158.89 | $368,148.13 |
DisclosureSEC source: 0001127602-15-003485 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,344 Read SEC document |
| May 12, 2014 Filed May 13, 2014 00:33 UTC | AMGEN INC AMGN · Entity 2832 | PurchaseCommon Stock | 894 | $111.77 | $99,919.25 |
DisclosureSEC source: 0001127602-14-017221 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,013 F1 · price: The price reported is an average price. The prices ranged from $111.758 to $111.769 per share. Full information regarding the number of shares purchased at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 7,140 RSUs which vest in one installment on 4/25/2015; 14,029 RSUs which vest in two installments of 6,910 and 7,119 on 4/27/2015 and 4/27/2016, respectively; 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 15,132 RSUs which vest in three installments of 4,993, 4,994 and 5,145 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 1,037 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 21:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 135 | $111.41 | $15,040.35 |
DisclosureSEC source: 0001127602-14-015501 · form4.xml · nonDerivative · entry 5 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,119 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 7,140 RSUs which vest in one installment on 4/25/2015; 14,029 RSUs which vest in two installments of 6,910 and 7,119 on 4/27/2015 and 4/27/2016, respectively; 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 15,132 RSUs which vest in three installments of 4,993, 4,994 and 5,145 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 1,037 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 21:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,606 | $111.41 | $401,744.46 |
DisclosureSEC source: 0001127602-14-015501 · form4.xml · nonDerivative · entry 4 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,254 Read SEC document |
| April 26, 2014 Filed Apr 29, 2014 21:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 783 | $111.41 | $87,234.03 |
DisclosureSEC source: 0001127602-14-015501 · form4.xml · nonDerivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,860 Read SEC document |
| April 26, 2014 Filed Apr 29, 2014 21:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,566 | $111.41 | $174,468.06 |
DisclosureSEC source: 0001127602-14-015501 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,643 Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 21:32 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,617 | $113.72 | $411,325.24 |
DisclosureSEC source: 0001127602-14-015501 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,209 Read SEC document |
| March 14, 2014 Filed Mar 18, 2014 20:20 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 26,891 | $123.96 | $3,333,408.36 |
DisclosureSEC source: 0001127602-14-012004 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,826 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,500 RSUs which fully vest on 4/26/2014; 14,070 RSUs which vest in one installment of 6,930 on 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 15,132 RSUs which vest in three installments of 4,993, 4,994 and 5,145 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 1,294 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:27 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 51,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-010749 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,439 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,500 RSUs which fully vest on 4/26/2014; 14,070 RSUs which vest in one installment of 6,930 on 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 15,132 RSUs which vest in three installments of 4,993, 4,994 and 5,145 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 1,016 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| February 12, 2014 Filed Feb 14, 2014 21:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionIso (Right to Buy) · Derivative | 6,392 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-14-006457 · form4.xml · derivative · entry 5 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,392 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2014 Filed Feb 14, 2014 21:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 58,608 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-14-006457 · form4.xml · derivative · entry 4 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,608 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2014 Filed Feb 14, 2014 21:19 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 47,135 | $121.24 | $5,714,647.40 |
DisclosureSEC source: 0001127602-14-006457 · form4.xml · nonDerivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,905 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,500 RSUs which fully vest on 4/26/2014; 14,070 RSUs which vest in one installment of 6,930 on 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 15,132 RSUs which vest in three installments of 4,993, 4,994 and 5,145 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 1,016 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| February 12, 2014 Filed Feb 14, 2014 21:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 6,392 | $62.55 | $399,819.60 |
DisclosureSEC source: 0001127602-14-006457 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2014 Filed Feb 14, 2014 21:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 58,608 | $62.55 | $3,665,930.40 |
DisclosureSEC source: 0001127602-14-006457 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 22:40 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 15,132 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-004379 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,040 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 4,500 RSUs which fully vest on 4/26/2014; 14,070 RSUs which vest in one installment of 6,930 on 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 15,132 RSUs which vest in three installments of 4,993, 4,994 and 5,145 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 1,016 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 28, 2013 Filed Apr 30, 2013 21:11 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,566 | $108.38 | $169,723.08 |
DisclosureSEC source: 0001127602-13-014767 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,379 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/26/2014; 1,500 RSUs which fully vest on 4/26/2014; 14,070 RSUs which vest in one installment of 6,930 on 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 487 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:11 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,349 | $108.66 | $255,242.34 |
DisclosureSEC source: 0001127602-13-014767 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,945 Read SEC document |
| April 25, 2013 Filed Apr 29, 2013 21:57 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,617 | $104.93 | $379,531.81 |
DisclosureSEC source: 0001127602-13-014703 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,294 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; 14,070 RSUs which vest in one installment of 6,930 on 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 487 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 15, 2013 Filed Mar 19, 2013 23:40 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 18,046 | $92.18 | $1,663,480.28 |
DisclosureSEC source: 0001127602-13-011470 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,911 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 487 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 06, 2013 Filed Mar 8, 2013 23:29 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 34,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-010165 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,755 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 285 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2013 Filed Jan 31, 2013 01:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 18,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-003271 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,171 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015; 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 18,693 RSUs which vest in three installments of 6,168, 6,169 and 6,356 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 285 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 20, 2012 Filed Dec 20, 2012 23:34 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $64.56 | $0.00 |
DisclosureSEC source: 0001127602-12-034798 · form4.xml · derivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2013-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2012 Filed Dec 20, 2012 23:34 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 34,233 | $88.49 | $3,029,278.17 |
DisclosureSEC source: 0001127602-12-034798 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,478 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015; and 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 285 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| December 20, 2012 Filed Dec 20, 2012 23:34 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 40,000 | $64.56 | $2,582,400.00 |
DisclosureSEC source: 0001127602-12-034798 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2012 Filed May 2, 2012 00:42 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $71.64 | $100,367.64 |
DisclosureSEC source: 0001127602-12-015247 · form4.xml · nonDerivative · entry 3 Bradway Robert A · CIK 0001396482 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,426 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015; and 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2012 Filed May 2, 2012 00:42 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $71.64 | $100,367.64 |
DisclosureSEC source: 0001127602-12-015247 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,827 Read SEC document |
| April 27, 2012 Filed May 2, 2012 00:42 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 20,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015247 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,228 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Read SEC document |
| April 26, 2012 Filed Apr 30, 2012 21:09 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,102 | $70.19 | $147,539.38 |
DisclosureSEC source: 0001127602-12-014948 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,290 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; and 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 21:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 5,017 | $68.26 | $342,460.42 |
DisclosureSEC source: 0001127602-12-011442 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,392 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 4,500 RSUs which vest in three equal annual installments of 1,500 each commencing 4/26/2012; and 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 14, 2012 Filed Mar 15, 2012 23:47 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 10,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-010811 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,409 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 4,500 RSUs which vest in three equal annual installments of 1,500 each commencing 4/26/2012; and 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2011 Filed May 2, 2011 23:12 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $57.14 | $80,053.14 |
DisclosureSEC source: 0001127602-11-014440 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,489 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/29/2012; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/28/2012; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 4,500 RSUs which vest in three equal annual installments of 1,500 each commencing 4/26/2012; and 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2011 Filed May 2, 2011 23:12 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $56.82 | $79,604.82 |
DisclosureSEC source: 0001127602-11-014440 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,890 Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 01:08 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 701 | $54.69 | $38,337.69 |
DisclosureSEC source: 0001127602-11-013882 · form4.xml · nonDerivative · entry 3 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,291 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/26/2012; 4,500 RSUs which vest in three equal annual installments of 1,500 each commencing 4/26/2012; and 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 01:08 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $54.69 | $76,620.69 |
DisclosureSEC source: 0001127602-11-013882 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,992 Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 01:08 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 73,500 | $54.69 Strike: $54.69 | $4,019,715.00 |
DisclosureSEC source: 0001127602-11-013882 · form4.xml · derivative · entry 4 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,500 Underlying: Common Stock · 73,500 shares Expires 2021-04-25 F3 · derivative.exercise_date: These non-qualified stock options are exercisable in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 01:08 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013882 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,393 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 11, 2011 Filed Mar 15, 2011 22:40 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 8,179 | $51.84 | $423,999.36 |
DisclosureSEC source: 0001127602-11-010294 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,393 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/26/2011; and 6,000 RSUs which vest in four equal annual installments of 1,500 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 02, 2011 Filed Mar 5, 2011 00:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 17,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-009091 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,572 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/26/2011; and 6,000 RSUs which vest in four equal annual installments of 1,500 each commencing 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| July 17, 2010 Filed Jul 20, 2010 21:45 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,751 | $52.17 | $91,349.67 |
DisclosureSEC source: 0001127602-10-019565 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,052 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/26/2011; and 6,000 RSUs which vest in four equal annual installments of 1,500 each commencing on 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:51 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $58.18 | $81,510.18 |
DisclosureSEC source: 0001127602-10-012671 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Executive V.P. and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,803 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,750 RSUs which vest on 7/17/2009; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vests in three equal annual installments of 3,000 each commencing 4/28/2011; 12,000 RSUs which vest in four equal installments of 3,000 each commencing 4/26/2011; and 6,000 RSUs which vest in four equal annual installments of 1,500 each commencing on 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:51 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,401 | $57.84 | $81,033.84 |
DisclosureSEC source: 0001127602-10-012671 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Executive V.P. and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,204 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:16 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 43,000 | $58.43 Strike: $58.43 | $2,512,490.00 |
DisclosureSEC source: 0001127602-10-012244 · form4.xml · derivative · entry 4 Bradway Robert A · CIK 0001396482 · Executive V.P. and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 43,000 shares Expires 2020-04-26 F5 · derivative.exercise_date: These options are exercisable in four equal annual installments of 25% each commencing 04/26/2011. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:16 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 84,000 | $58.43 Strike: $58.43 | $4,908,120.00 |
DisclosureSEC source: 0001127602-10-012244 · form4.xml · derivative · entry 3 Bradway Robert A · CIK 0001396482 · Executive V.P. and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2020-04-26 F4 · derivative.exercise_date: These options are exercisable in four equal annual installments of 25% each commencing 04/26/2011. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:16 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012244 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Executive V.P. and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,605 F2 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest in four equal annual installments of 25% each commencing April 26, 2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 3,750 RSUs which vest on 7/17/2010; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/28/2010; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/26/2011; and 6,000 RSUs which vest in four equal annual installments of 1,500 each commencing on 4/26/2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:16 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012244 · form4.xml · nonDerivative · entry 1 Bradway Robert A · CIK 0001396482 · Executive V.P. and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,605 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest in four equal annual installments of 25% each commencing April 26, 2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 18:08 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 5,753 | $57.49 | $330,739.97 |
DisclosureSEC source: 0001127602-10-008766 · form4.xml · nonDerivative · entry 2 Bradway Robert A · CIK 0001396482 · Executive V.P. and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,605 F1 · security: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 3,750 RSUs which vest on 7/17/2010; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.